Tumor News and Research

RSS

Investigational compound inhibits cancer-specific mutations in mice

Many malignancies develop as a result of genetic alterations in individual cells. These gene mutations often cause altered proteins that give new, growth-promoting properties to the cell.

30 May 2017

Radiopharmaceutical for cancer diagnosis is ready for preclinical-phase trial

A radiopharmaceutical for advanced identification of cancer, labeled with the technetium-99 isotope, is ready for the preclinical-phase trial.

30 May 2017

Researchers develop new mouse model that could lead to better treatment of kidney cancer

Research in the field of kidney cancer, also called renal cancer, is vital, because many patients with this disease still cannot be cured today.

30 May 2017

JGU chemists develop technique that reduces toxic effects of cigarettes

Chemists at Johannes Gutenberg University Mainz have developed a technique that reduces the toxic effects of commercially available cigarettes.

30 May 2017

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.

29 May 2017

Researchers can attack cancer by working together, says UNC Charlotte professor

MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.

27 May 2017

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

Dragon Master Foundation has announced plans to provide $300,000 in funding for the first clinical trial that will make patient data available live in the cloud while the trial is underway.

27 May 2017

Researchers use chemical array to find malignant cells within melanoma tumor

Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within a melanoma tumor that hold the potential to spread.

26 May 2017

Some types of cancers are heavily dependent on sugar, study shows

In a new study, scientists at The University of Texas at Dallas have found that some types of cancers have more of a sweet tooth than others.

26 May 2017

Combined use of two existing drugs appears to slow cancer's tendency to spread, study shows

A team led by Johns Hopkins researchers has discovered a biochemical signaling process that causes densely packed cancer cells to break away from a tumor and spread the disease elsewhere in the body.

26 May 2017

Swiss scientists create artificial viruses to combat cancer cells

Swiss scientists from the University of Geneva, Switzerland, and the University of Basel have created artificial viruses that can be used to target cancer.

26 May 2017

Norwegian study shows huge potential of Sigmascreening’s pressure based paddle for women’s health

Sigmascreening, a Dutch MedTech developer and world leader in the field of pressure based digital mammography and breast cancer screening, announces that a large independent Norwegian study further confirms Sigma’s hypothesis that pressure has a clear relation with the most optimal results in mammography.

26 May 2017

Study reveals how enzyme allows brain tumors to grow despite harsh surroundings

All cancer tumors have one thing in common – they must feed themselves to grow and spread, a difficult feat since they are usually in a tumor microenvironment with limited nutrients and oxygen.

26 May 2017

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

25 May 2017

Scientists identify genetic risk factor for equine squamous cell carcinoma

Squamous cell carcinoma (SCC) is the most common cancer found in equine eyes and the second most common tumor of the horse overall. Thanks to a recent genetic study led by UC Davis, horse owners can now identify horses at risk for ocular SCC and make informed breeding decisions.

25 May 2017

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage breast cancer often undergo advanced imaging and other tests that provide little if any medical benefit, could have harmful effects and may increase their financial burden.

25 May 2017

Review: Medical image denoising using machine learning techniques for better diagnostic accuracy

Machine learning techniques are increasingly demonstrating success in image-based diagnosis, disease detection and disease prognosis.

24 May 2017

Bioadhesive nanoparticles show potential for drug delivery to specific cells in the brain

A Yale research team has found that by tinkering with the surface properties of drug-loaded nanoparticles, they can potentially direct these particles to specific cells in the brain.

24 May 2017

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

A team of researchers from the National University of Singapore has developed a novel handheld device, known as CLiKX, for the treatment of a condition called Otitis Media with Effusion, or 'glue ear', which is the leading cause of hearing loss and visits to the doctors among children worldwide.

24 May 2017

Sleep disturbances, long and short duration of sleep may increase risk of dementia and lung cancer

Difficulties in initiating or maintaining sleep at middle-age are associated with an increased risk of dementia, according to a new study from the University of Eastern Finland.

24 May 2017

Tumor News and Research

Investigational compound inhibits cancer-specific mutations in mice

Radiopharmaceutical for cancer diagnosis is ready for preclinical-phase trial

Researchers develop new mouse model that could lead to better treatment of kidney cancer

JGU chemists develop technique that reduces toxic effects of cigarettes

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Researchers can attack cancer by working together, says UNC Charlotte professor

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

Researchers use chemical array to find malignant cells within melanoma tumor

Some types of cancers are heavily dependent on sugar, study shows

Combined use of two existing drugs appears to slow cancer's tendency to spread, study shows

Swiss scientists create artificial viruses to combat cancer cells

Norwegian study shows huge potential of Sigmascreening’s pressure based paddle for women’s health

Study reveals how enzyme allows brain tumors to grow despite harsh surroundings

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

Scientists identify genetic risk factor for equine squamous cell carcinoma

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

Review: Medical image denoising using machine learning techniques for better diagnostic accuracy

Bioadhesive nanoparticles show potential for drug delivery to specific cells in the brain

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

Sleep disturbances, long and short duration of sleep may increase risk of dementia and lung cancer

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News